These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22389904)

  • 21. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Lannon MC; Friedman JH; Abbott BP
    Mov Disord; 2000 May; 15(3):579-81. PubMed ID: 10830427
    [No Abstract]   [Full Text] [Related]  

  • 22. Quetiapine for olanzapine-induced galactorrhea.
    Kingsbury SJ; Castelo C; Abulseoud O
    Am J Psychiatry; 2002 Jun; 159(6):1061. PubMed ID: 12042203
    [No Abstract]   [Full Text] [Related]  

  • 23. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 24. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 25. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease.
    Brandstädter D; Oertel WH
    Neurology; 2002 Jan; 58(1):160-1. PubMed ID: 11781441
    [No Abstract]   [Full Text] [Related]  

  • 27. The paradox of quetiapine in obsessive-compulsive disorder.
    Tranulis C; Potvin S; Gourgue M; Leblanc G; Mancini-Marie A; Stip E
    CNS Spectr; 2005 May; 10(5):356-61. PubMed ID: 15858452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination treatment with quetiapine in bipolar disorder patients.
    Basu D; Chakraborty K
    Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
    [No Abstract]   [Full Text] [Related]  

  • 29. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.
    Pui-yin Chung J; Shiu-yin Chong C; Chung KF; Lai-wah Dunn E; Wai-nang Tang O; Chan WF
    Can J Psychiatry; 2008 Dec; 53(12):857-62. PubMed ID: 19087484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia with quetiapine.
    Ghelber D; Belmaker RH
    Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
    [No Abstract]   [Full Text] [Related]  

  • 33. Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
    Tracy DK; Joyce DW; Sarkar SN; Mateos Fernandez MJ; Shergill SS
    BMC Psychiatry; 2015 Jul; 15():174. PubMed ID: 26205327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior.
    Brooks JO
    Schizophr Res; 2001 May; 50(1-2):133-4. PubMed ID: 11378322
    [No Abstract]   [Full Text] [Related]  

  • 35. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation.
    Hanisch F; Friedemann J; Pillmann F
    J Psychopharmacol; 2010 Nov; 24(11):1725-6. PubMed ID: 19939868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia].
    Danilov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):48-55. PubMed ID: 20517226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic Inflammatory Response Syndrome Associated With Clozapine and Successful Rechallenge: A Case Report.
    Ramasamy RS; Bronson B; Lerman M
    J Clin Psychopharmacol; 2016 Feb; 36(1):93-5. PubMed ID: 26658088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.